ASX:NXNPharmaceuticals, Biotechnology & Life SciencesBiotechnology
Nexsen Ltd
$0.220
$0.005 (2.22%)
Day Range
$0.220 – $0.220
52 Week Range
$0.130 – $0.315
Volume
32.50K
Avg Volume (10D)
199.83K
Market Cap
$20.41M
Price Chart
Market Statistics
Open$0.220
Previous Close$0.225
Day High$0.220
Day Low$0.220
52 Week High$0.315
52 Week Low$0.130
Valuation
Market Cap20.41M
Shares Outstanding92.77M
Trading Activity
Volume32.50K
Value Traded7.15K
Bid$0.215 × 13,953
Ask$0.220 × 40,000
Performance
1 Day-6.12%
5 Day0.00%
13 Week39.39%
YTD43.75%
Technical Indicators
RSI (14)45.86
50-Day SMA$0.217
Latest News
Biotechnology
Nexsen Secures First Asian Hospital Partner for Diagnostic Commercialisation
Nexsen signs binding term sheet with GHK Hospital to validate and roll out rapid point-of-care diagnostics in North Asia, starting with GBS and kidney tests.
Biotechnology
Nexsen Awarded $1.2m Grant to Advance Strepsure Point-Of-Care Diagnostic in Asia-Pacific Markets
Nexsen awarded $1.2m grant to advance StrepSure GBS test in Asia-Pacific; Hong Kong as hub for validation, local manufacturing and near-term commercialization.